REQUEST A DEMO
Total
USD $0.00
Search more companies

Solace Biotech Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Solace Biotech Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Solace Biotech Limited is an unlisted company, incorporated on 22/07/2013. It has its registered office in the State of Haryana, India. Company's corporate identification number (CIN) is U24232HR2013PLC049887 and registration number is 049887. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Plot No. 195, Sector-2 Phase-1, Food Park, Industrial Estate
Ambala; Haryana; Postal Code: 133104

Contact Details: Purchase the Solace Biotech Limited report to view the information.

Basic Information
Total Employees:
Purchase the Solace Biotech Limited report to view the information.
Outstanding Shares:
Purchase the Solace Biotech Limited report to view the information.
Registered Capital:
Purchase the Solace Biotech Limited report to view the information.
Incorporation Date:
July 22, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
91.67%
Purchase this report to view the information.
8.1%
Company Performance
Financial values in the chart are available after Solace Biotech Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-25.96%
Total operating revenue
-27%
Operating profit (EBIT)
-24.65%
EBITDA
-9.85%
Net Profit (Loss) for the Period
-48.89%
Total assets
2.37%
Total equity
1.83%
Operating Profit Margin (ROS)
0.02%
Net Profit Margin
-0.15%
Return on Equity (ROE)
-3.28%
Debt to Equity Ratio
114.96%
Quick Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?